CN103007158A - Traditional Chinese medicine for treating gastric cancer and preparation method of medicine - Google Patents
Traditional Chinese medicine for treating gastric cancer and preparation method of medicine Download PDFInfo
- Publication number
- CN103007158A CN103007158A CN2012105825105A CN201210582510A CN103007158A CN 103007158 A CN103007158 A CN 103007158A CN 2012105825105 A CN2012105825105 A CN 2012105825105A CN 201210582510 A CN201210582510 A CN 201210582510A CN 103007158 A CN103007158 A CN 103007158A
- Authority
- CN
- China
- Prior art keywords
- parts
- gastric cancer
- chinese medicine
- herba
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010017758 gastric cancer Diseases 0.000 title claims abstract description 32
- 208000005718 Stomach Neoplasms Diseases 0.000 title claims abstract description 31
- 201000011549 stomach cancer Diseases 0.000 title claims abstract description 31
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 241000255789 Bombyx mori Species 0.000 claims abstract description 12
- 244000234609 Portulaca oleracea Species 0.000 claims abstract description 12
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 12
- 241000717679 Mosla Species 0.000 claims abstract description 7
- 241001078983 Tetradium ruticarpum Species 0.000 claims abstract description 7
- 241000628997 Flos Species 0.000 claims description 11
- 240000008669 Hedera helix Species 0.000 claims description 11
- 235000006439 Lemna minor Nutrition 0.000 claims description 11
- 210000000582 semen Anatomy 0.000 claims description 11
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 11
- 244000025254 Cannabis sativa Species 0.000 claims description 7
- 235000013422 Kaempferia rotunda Nutrition 0.000 claims description 6
- 241000219295 Portulaca Species 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 244000062250 Kaempferia rotunda Species 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 abstract description 15
- 210000000952 spleen Anatomy 0.000 abstract description 7
- 206010028980 Neoplasm Diseases 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 201000011510 cancer Diseases 0.000 abstract description 2
- 238000009792 diffusion process Methods 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000002035 prolonged effect Effects 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract 2
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract 1
- 244000062241 Kaempferia galanga Species 0.000 abstract 1
- 235000013421 Kaempferia galanga Nutrition 0.000 abstract 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract 1
- 235000018996 Nuphar luteum Nutrition 0.000 abstract 1
- 244000020186 Nymphaea lutea Species 0.000 abstract 1
- 235000018949 Nymphaea lutea Nutrition 0.000 abstract 1
- 240000003731 Piper cubeba Species 0.000 abstract 1
- 235000002711 Piper cubeba Nutrition 0.000 abstract 1
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 abstract 1
- 241000123725 Sophora tonkinensis Species 0.000 abstract 1
- 241000046198 Triteleia hyacinthina Species 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 6
- 241000395033 Kaempferia Species 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 230000004087 circulation Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 208000009956 adenocarcinoma Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000007661 gastrointestinal function Effects 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000003252 Signet Ring Cell Carcinoma Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000008395 adenosquamous carcinoma Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 208000002458 carcinoid tumor Diseases 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000010749 gastric carcinoma Diseases 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000002962 histologic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 201000011591 microinvasive gastric cancer Diseases 0.000 description 1
- 201000010879 mucinous adenocarcinoma Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 208000004019 papillary adenocarcinoma Diseases 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 210000004203 pyloric antrum Anatomy 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 201000008123 signet ring cell adenocarcinoma Diseases 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 201000007423 tubular adenocarcinoma Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000010576 undifferentiated carcinoma Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating a gastric cancer and a preparation method of the medicine, which belong to the technical field of traditional Chinese medicines. The traditional Chinese medicine for treating the gastric cancer comprises the following raw materials in parts by weight: 15-20 parts of vietnamese sophora root, 8-15 parts of houttuynia cordata, 5-10 parts of uniflower swisscentaury root, 10-18 parts of Chinese mosla herb, 8-16 parts of mangnolia officinalis, 5-10 parts of white hyacinth bean, 10-20 parts of silkworm excrement, 8-18 of purslane, 6-15 parts of malt, 10-18 parts of mume flower, 6-15 parts of yellow water lily, 8-15 parts of folium isatidis, 5-15 parts of evodia rutaecarpa, 8-12 parts of cubeb, 6-10 parts of galangal and 5-10 parts of rhizoma kaempferiae. The traditional Chinese medicine for treating the gastric cancer has the advantages of being capable of clearing away heat and toxic materials, strengthening spleen and stomach and warning spleen and stomach for dispelling cold, being reasonable in compatibility of medicines so as to bring out the best of the medicines, and being capable of enhancing the immunity of the organism, alleviating clinical symptoms, inhibiting the transfer and diffusion of cancer cells, reducing toxicity and enhancing efficacy, so that the life quality of patients is improved, and the life of the patients is prolonged.
Description
Technical field
The present invention relates to Chinese medicine for the treatment of gastric cancer and preparation method thereof, belong to technical field of Chinese medicines.
Background technology
Gastric cancer originates from the mucomembranous epithelial cell on the top layer of coat of the stomach, can betide each position (the gastric antrum pylorus district at most, take second place in the cardia district at the bottom of the stomach, body of stomach is less slightly) of stomach, can invade different depth and the range of coat of the stomach.Cancer is confined in the mucosa or the submucosal early gastric cancer that is called, and invades the flesh layer with dark or transfer to stomach and be called advanced gastric carcinoma with the exterior domain person.Naked eyes or gastroscopic observation gastric cancer have variform, as show shallow type, mass-type, ulcer type, infiltrative type, ulcerocancer (for the chronic gastric ulcer canceration).Microscope amplifying observation cancerous cell has polytype (histologic classification), such as adenocarcinoma (account for about 90%, comprise papillary adenocarcinoma, tubular adenocarcinoma, mucinous adenocarcinoma, signet-ring cell carcinoma), adenosquamous carcinoma, squamous cell carcinoma, undifferentiated carcinoma, carcinoid.The molecular structure of trickleer cancerous cell inside also has a lot of differences, and therefore, though all be called gastric cancer, even naked eyes are identical with microscopically finding type, individual character still has very big-difference, does not know the gastric cancer how many individual character uniquenesses are arranged actually at present.The annual new gastric cancer more than 100 ten thousand in the whole world, China accounts for 42%, and dead about 800,000, China accounts for 35%, is one of the highest country of incidence gastric cancer rate and mortality rate, and M ﹠ M all is that the world average level twice is many.2007, in front 10 cancers of China, (1) incidence gastric cancer rate was second, and mortality rate is the 3rd; (2) men and women's of M ﹠ M ratio is 2 to 1; (3) sickness rate in rural area is that 1.6 times of the city, the mortality rate in rural area are 1.9 times of city; (4) death/incidence rate (be equivalent to ill after the risk of dying of illness) is the 8th.The sickness rate of gastric cancer significantly raises along with the increase at age, and the peak age of morbidity is at 50 years old～80 years old, but presents year by year rejuvenation trend, and 19～35 years old patient's ratio rises to current 3.3% from 1.7% over 40 years in the gastric cancer.Generally all adopt operative therapy, chemotherapy, pharmacotherapy etc., but the said method effect is all very not obvious, but also with a lot of complication, is difficult for being accepted by the patient.
Summary of the invention
The object of the invention is to solve the weak point that above-mentioned prior art exists, thus provide a kind of curative effect obviously, have no side effect, can delay the Chinese medicine and preparation method thereof that PD speed prolongs the treatment gastric cancer in patient's life-span.
The present invention is achieved by the following technical solutions:
A kind of Chinese medicine for the treatment of gastric cancer, its special character are to be comprised of following raw material by weight ratio: Radix Sophorae Tonkinensis 15-20 part, Herba Houttuyniae 8-15 part, Radix Rhapontici 5-10 part, Herba Moslae 10-18 part, Cortex Magnoliae Officinalis 8-16 part, Semen Lablab Album 5-10 part, silkworm excrement 10-20 part, Herba Portulacae 8-18 part, Fructus Hordei Germinatus 6-15 part, FLOS MUME 10-18 part, duckweed meet careless 6-15 part, Folium Isatidis 8-15 part, Fructus Evodiae 5-15 part, Fructus Litseae 8-12 part, Rhizoma Alpiniae Officinarum 6-10 part, Rhizoma Kaempferiae 5-10 part;
The Chinese medicine of described treatment gastric cancer is comprised of following raw material by weight ratio: Radix Sophorae Tonkinensis 18-20 part, Herba Houttuyniae 10-15 part, Radix Rhapontici 8-10 part, Herba Moslae 12-18 part, Cortex Magnoliae Officinalis 8-14 part, Semen Lablab Album 8-10 part, silkworm excrement 15-20 part, Herba Portulacae 10-18 part, Fructus Hordei Germinatus 8-15 part, FLOS MUME 15-18 part, duckweed meet careless 8-15 part, Folium Isatidis 12-15 part, Fructus Evodiae 5-10 part, Fructus Litseae 10-12 part, Rhizoma Alpiniae Officinarum 8-10 part, Rhizoma Kaempferiae 6-10 part;
The Chinese medicine of described treatment gastric cancer is comprised of the raw material of following by weight optimal proportion: 20 parts of Radix Sophorae Tonkinensiss, 10 parts of Herba Houttuyniae, 8 parts of Radix Rhapontici, 12 parts of Herba Moslaes, 10 parts of Cortex Magnoliae Officinalis, 6 parts of Semen Lablab Albums, 12 parts of silkworm excrements, 15 parts of Herba Portulacaes, 12 parts in Fructus Hordei Germinatus, 15 parts of FLOS MUME, duckweed meet 8 parts of grass, 9 parts of Folium Isatidiss, 8 parts of Fructus Evodiaes, 10 parts of Fructus Litseae, 8 parts of Rhizoma Alpiniae Officinarums, 6 parts of Rhizoma Kaempferiaes;
A kind of preparation method for the treatment of the Chinese medicine of gastric cancer, its special character is may further comprise the steps:
(1) each raw material of Chinese medicine is taken by weighing by weight, soaked 2 hours;
(2) decoct to boiling with high heat first, used again slow fire boiling 2 hours;
(3) filter, take out medicinal residues;
(4) last medicinal residues are decocted with water 2 hours again, taking liquid is taken.
The effect of each Chinese medicinal components:
Radix Sophorae Tonkinensis: hardship, cold, relieve inflammation or internal heat detoxifcation;
Herba Houttuyniae: acrid in the mouth, tepor, heat-clearing and toxic substances removing;
Radix Rhapontici: bitter in the mouth is salty, heat-clearing and toxic substances removing, and Shujin is promoted blood circulation;
Herba Moslae: acrid-sweet flavor, warm in nature, relieving the exterior syndrome by diaphoresis, removing dampness for regulating stomach;
Cortex Magnoliae Officinalis: hardship, suffering, the circulation of qi promoting removing food stagnancy, dampness is except full;
Semen Lablab Album: sweet, tepor, spleen reinforcing and in;
Silkworm excrement: Gan Wen, dampness is dispeled the wind, regulating the function of the stomach to resolve the turbidity;
Herba Portulacae: cold in nature, sweet in the mouth acid, heat-clearing and toxic substances removing, diuretic damp eliminating;
Fructus Hordei Germinatus: sweet, flat, promote qi circulation digestion promoting, spleen benefiting and stimulating the appetite;
FLOS MUME: sour and astringent, flat, soothing liver-QI, stomach function regulating;
Duckweed meets grass: regulating the function of the stomach to resolve the turbidity;
Folium Isatidis: bitter in the mouth, cold, heat-clearing and toxic substances removing;
Fructus Evodiae: acrid in the mouth, temperature, warming the middle warmer and descending qi;
Fructus Litseae: acrid in the mouth, warm in nature, warming spleen and stomach for dispelling cold, promoting the circulation of QI to relieve pain;
Rhizoma Alpiniae Officinarum: suffering, heat, warming stomach for dispelling cold, pain relieving helps digestion;
Rhizoma Kaempferiae: suffering, temperature, the circulation of qi promoting warming middle-JIAO, pain relieving helps digestion.
The present invention treats the Chinese medicine of gastric cancer, can heat-clearing and toxic substances removing, invigorating the spleen and regulating the stomach, warming spleen and stomach for dispelling cold, and compatibility is reasonable, brings out the best in each other, enhancing human body immunity power is improved clinical symptoms, has suppressed transfer and the diffusion of cancerous cell, attenuation synergistic has improved Quality of Life, has prolonged patient's life-span.
The specific embodiment
Below provide the specific embodiment of the present invention, be used for formation of the present invention is described in further detail.
Embodiment 1
The Chinese medicine of present embodiment treatment gastric cancer, be comprised of following raw material by weight ratio: 15 parts of Radix Sophorae Tonkinensiss, 8 parts of Herba Houttuyniae, 5 parts of Radix Rhapontici, 10 parts of Herba Moslaes, 8 parts of Cortex Magnoliae Officinalis, 5 parts of Semen Lablab Albums, 10 parts of silkworm excrements, 8 parts of Herba Portulacaes, 6 parts in Fructus Hordei Germinatus, 10 parts of FLOS MUME, duckweed meet 6 parts of grass, 8 parts of Folium Isatidiss, 5 parts of Fructus Evodiaes, 8 parts of Fructus Litseae, 6 parts of Rhizoma Alpiniae Officinarums, 5 parts of Rhizoma Kaempferiaes.
Embodiment 2
The Chinese medicine of present embodiment treatment gastric cancer, be comprised of following raw material by weight ratio: 20 parts of Radix Sophorae Tonkinensiss, 15 parts of Herba Houttuyniae, 10 parts of Radix Rhapontici, 18 parts of Herba Moslaes, 16 parts of Cortex Magnoliae Officinalis, 10 parts of Semen Lablab Albums, 20 parts of silkworm excrements, 18 parts of Herba Portulacaes, 15 parts in Fructus Hordei Germinatus, 18 parts of FLOS MUME, duckweed meet 15 parts of grass, 15 parts of Folium Isatidiss, 15 parts of Fructus Evodiaes, 12 parts of Fructus Litseae, 10 parts of Rhizoma Alpiniae Officinarums, 10 parts of Rhizoma Kaempferiaes.
Embodiment 3
The Chinese medicine of present embodiment treatment gastric cancer, be comprised of following raw material by weight ratio: 18 parts of Radix Sophorae Tonkinensiss, 12 parts of Herba Houttuyniae, 8 parts of Radix Rhapontici, 14 parts of Herba Moslaes, 14 parts of Cortex Magnoliae Officinalis, 6 parts of Semen Lablab Albums, 15 parts of silkworm excrements, 14 parts of Herba Portulacaes, 10 parts in Fructus Hordei Germinatus, 14 parts of FLOS MUME, duckweed meet 8 parts of grass, 12 parts of Folium Isatidiss, 10 parts of Fructus Evodiaes, 10 parts of Fructus Litseae, 8 parts of Rhizoma Alpiniae Officinarums, 8 parts of Rhizoma Kaempferiaes.
Embodiment 4
The Chinese medicine of present embodiment treatment gastric cancer, be comprised of the raw material of following by weight optimal proportion: 20 parts of Radix Sophorae Tonkinensiss, 10 parts of Herba Houttuyniae, 8 parts of Radix Rhapontici, 12 parts of Herba Moslaes, 10 parts of Cortex Magnoliae Officinalis, 6 parts of Semen Lablab Albums, 12 parts of silkworm excrements, 15 parts of Herba Portulacaes, 12 parts in Fructus Hordei Germinatus, 15 parts of FLOS MUME, duckweed meet 8 parts of grass, 9 parts of Folium Isatidiss, 8 parts of Fructus Evodiaes, 10 parts of Fructus Litseae, 8 parts of Rhizoma Alpiniae Officinarums, 6 parts of Rhizoma Kaempferiaes;
The preparation method of the Chinese medicine of above-mentioned treatment gastric cancer may further comprise the steps:
(1) each raw material of Chinese medicine is taken by weighing by weight, soaked 2 hours;
(2) decoct to boiling with high heat first, used again slow fire boiling 2 hours;
(3) filter, take out medicinal residues;
(4) last medicinal residues are decocted with water 2 hours again, taking liquid is taken.
Test example:
Test patient totally 178 examples, male's 96 examples wherein, women's 82 examples all suffer from gastric cancer.
Criterion of therapeutical effect:
Produce effects: after 4 course of therapy, patient's gastrointestinal function recovers, and appetite is normal, and body constitution is recovered;
Take a turn for the better: patient's sx↓, gastrointestinal function takes a turn for the better, and it is normal that body constitution is recovered substantially;
Invalid: treatment is rear without any effect;
It below is therapeutic effect
| The case sum | Produce effects example number | Routine number takes a turn for the better | Invalid routine number | Total effective rate |
| 178 | 126 | 47 | 5 | 97.19% |
Claims (4)
1. Chinese medicine for the treatment of gastric cancer, it is characterized in that being comprised of following raw material by weight ratio: Radix Sophorae Tonkinensis 15-20 part, Herba Houttuyniae 8-15 part, Radix Rhapontici 5-10 part, Herba Moslae 10-18 part, Cortex Magnoliae Officinalis 8-16 part, Semen Lablab Album 5-10 part, silkworm excrement 10-20 part, Herba Portulacae 8-18 part, Fructus Hordei Germinatus 6-15 part, FLOS MUME 10-18 part, duckweed meet careless 6-15 part, Folium Isatidis 8-15 part, Fructus Evodiae 5-15 part, Fructus Litseae 8-12 part, Rhizoma Alpiniae Officinarum 6-10 part, Rhizoma Kaempferiae 5-10 part.
2. described a kind of Chinese medicine for the treatment of gastric cancer according to claim 1, it is characterized in that being comprised of following raw material by weight ratio: Radix Sophorae Tonkinensis 18-20 part, Herba Houttuyniae 10-15 part, Radix Rhapontici 8-10 part, Herba Moslae 12-18 part, Cortex Magnoliae Officinalis 8-14 part, Semen Lablab Album 8-10 part, silkworm excrement 15-20 part, Herba Portulacae 10-18 part, Fructus Hordei Germinatus 8-15 part, FLOS MUME 15-18 part, duckweed meet careless 8-15 part, Folium Isatidis 12-15 part, Fructus Evodiae 5-10 part, Fructus Litseae 10-12 part, Rhizoma Alpiniae Officinarum 8-10 part, Rhizoma Kaempferiae 6-10 part.
3. described a kind of Chinese medicine for the treatment of gastric cancer according to claim 1, it is characterized in that being comprised of the raw material of following by weight optimal proportion: 20 parts of Radix Sophorae Tonkinensiss, 10 parts of Herba Houttuyniae, 8 parts of Radix Rhapontici, 12 parts of Herba Moslaes, 10 parts of Cortex Magnoliae Officinalis, 6 parts of Semen Lablab Albums, 12 parts of silkworm excrements, 15 parts of Herba Portulacaes, 12 parts in Fructus Hordei Germinatus, 15 parts of FLOS MUME, duckweed meet 8 parts of grass, 9 parts of Folium Isatidiss, 8 parts of Fructus Evodiaes, 10 parts of Fructus Litseae, 8 parts of Rhizoma Alpiniae Officinarums, 6 parts of Rhizoma Kaempferiaes.
4. described a kind of preparation method for the treatment of the Chinese medicine of gastric cancer according to claim 1-3 is characterized in that may further comprise the steps:
(1) each raw material of Chinese medicine is taken by weighing by weight, soaked 2 hours;
(2) decoct to boiling with high heat first, used again slow fire boiling 2 hours;
(3) filter, take out medicinal residues;
(4) last medicinal residues are decocted with water 2 hours again, taking liquid is taken.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210582510.5A CN103007158B (en) | 2012-12-28 | 2012-12-28 | Traditional Chinese medicine for treating gastric cancer and preparation method of medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210582510.5A CN103007158B (en) | 2012-12-28 | 2012-12-28 | Traditional Chinese medicine for treating gastric cancer and preparation method of medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103007158A true CN103007158A (en) | 2013-04-03 |
| CN103007158B CN103007158B (en) | 2014-11-19 |
Family
ID=47956622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210582510.5A Active CN103007158B (en) | 2012-12-28 | 2012-12-28 | Traditional Chinese medicine for treating gastric cancer and preparation method of medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103007158B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103550633A (en) * | 2013-11-20 | 2014-02-05 | 孙晶晶 | Traditional Chinese medicine for treating stomach cancer of disharmony between liver and stomach type and preparation method thereof |
| CN105963552A (en) * | 2016-05-11 | 2016-09-28 | 德施普科技发展温州有限公司 | Traditional Chinese medicine composition for treating early gastric cancer with matching of argon knife and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101757566A (en) * | 2010-04-07 | 2010-06-30 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating colon cancer and preparation method thereof |
| CN101757598A (en) * | 2009-11-05 | 2010-06-30 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating advanced malignant liver tumor symptoms and preparation method thereof |
| CN101757567A (en) * | 2010-04-07 | 2010-06-30 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating rectal cancer and preparation method thereof |
-
2012
- 2012-12-28 CN CN201210582510.5A patent/CN103007158B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101757598A (en) * | 2009-11-05 | 2010-06-30 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating advanced malignant liver tumor symptoms and preparation method thereof |
| CN101757566A (en) * | 2010-04-07 | 2010-06-30 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating colon cancer and preparation method thereof |
| CN101757567A (en) * | 2010-04-07 | 2010-06-30 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating rectal cancer and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 叶丽红等: "周仲瑛教授的肿瘤观", 《中国中医药信息杂志》 * |
| 苏丽等: "膏方治疗恶性肿瘤探赜", 《辽宁中医杂志》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103550633A (en) * | 2013-11-20 | 2014-02-05 | 孙晶晶 | Traditional Chinese medicine for treating stomach cancer of disharmony between liver and stomach type and preparation method thereof |
| CN103550633B (en) * | 2013-11-20 | 2015-07-29 | 郝燕琴 | A kind ofly treat Chinese medicine of liver-stomach disharmony type gastric cancer and preparation method thereof |
| CN105963552A (en) * | 2016-05-11 | 2016-09-28 | 德施普科技发展温州有限公司 | Traditional Chinese medicine composition for treating early gastric cancer with matching of argon knife and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103007158B (en) | 2014-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101474317B (en) | Method for preparing Chinese medicine for treating wind-heat excess type blepharitis | |
| CN104474281A (en) | Traditional Chinese medicine formula for treating thyroid cancer | |
| CN104398831A (en) | Traditional Chinese medicine formula for treating thyroid cancer | |
| CN102309687B (en) | Medicament for treating faucitis | |
| CN103007158B (en) | Traditional Chinese medicine for treating gastric cancer and preparation method of medicine | |
| CN106110489A (en) | A kind of health care elbow support device treating elbow pain | |
| CN104069451A (en) | Traditional Chinese medicine composition for treating diarrhea | |
| CN103800842A (en) | Traditional Chinese medicine composition for treating carcinoma of urinary bladder | |
| CN105267890A (en) | Traditional Chinese medicine formula for treating lung cancer | |
| CN104623242A (en) | Traditional Chinese medicine formula for treating lung cancer and preparation method of traditional Chinese medicine formula | |
| CN102145096B (en) | Decoction for treating helicobacter pylori-associated gastritis | |
| CN104189791A (en) | Traditional Chinese medicine preparation for treating malaria | |
| CN104740042A (en) | Traditional Chinese medicine composition for treating chronic pharyngitis | |
| CN106692268A (en) | Production method of licorice root soup | |
| CN105497448A (en) | Traditional Chinese medicine preparation for treating breast cancer and preparation method thereof | |
| CN104800288A (en) | Traditional Chinese medicine for treating acute viral pharyngitis | |
| CN105311289A (en) | Formula of traditional Chinese medicine for treating lung cancer due to accumulation of phlegm dampness in lung | |
| CN103735997B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of gastric cancer | |
| CN103705856B (en) | For preventing the Chinese medicine composition of chemicotherapy acute radio-reaction | |
| CN113144161B (en) | Externally applied traditional Chinese medicine composition for treating pelvic inflammation and pelvic effusion | |
| CN102552801A (en) | Medicament for treating tumors | |
| CN105560747A (en) | Traditional Chinese medicine formula for treating lung cancer with syndrome of phlegm-damp amassing in lung | |
| CN105853882A (en) | Medicine for treating stomach illness and preparation method | |
| CN105535597A (en) | Compound medicine for treating gastroenteric tumor | |
| CN105125733A (en) | Traditional Chinese medicine for treating pollinosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent of invention or patent application | ||
| CB02 | Change of applicant information |
Address after: 264003 Yantai high tech Zone, China Agricultural University, Shandong (Yantai campus) Applicant after: Liu Yaohua Address before: Zhifu District of Shandong city of Yantai Province Yu 264000 West Road, room 205 No. 17-6 Applicant before: Liu Yaohua |
|
| ASS | Succession or assignment of patent right |
Owner name: SUN LIJUN Free format text: FORMER OWNER: LIU YAOHUA Effective date: 20141009 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Mei Inventor after: Li Change Inventor after: Guo Jianhong Inventor after: Cao Fengxia Inventor after: Nie Miao Inventor after: Sun Lijun Inventor before: Liu Yaohua Inventor before: Wang Lihua |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 264003 YANTAI, SHANDONG PROVINCE TO: 266600 QINGDAO, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: LIU YAOHUA WANG LIHUA TO: LI MEI LI CHANGE GUO JIANHONG CAO FENGXIA NIE MIAO SUN LIJUN |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20141009 Address after: 266600 Weihai East Road, Qingdao, Shandong, No. 43 Applicant after: Sun Lijun Address before: 264003 Yantai high tech Zone, China Agricultural University, Shandong (Yantai campus) Applicant before: Liu Yaohua |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: Jiangning District, Tangshan street west Nanjing City, Jiangsu province 211100 Building No. 18 Patentee after: Sun Lijun Address before: 266600 Weihai East Road, Qingdao, Shandong, No. 43 Patentee before: Sun Lijun |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170417 Address after: 226100 Nantong Province Haimen City, Yue Yue town government compound Patentee after: Nantong Yue Yue Industrial Co., Ltd. Address before: Jiangning District, Tangshan street west Nanjing City, Jiangsu province 211100 Building No. 18 Patentee before: Sun Lijun |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181225 Address after: 331200 Zhangshu North Industrial Park, Yichun City, Jiangxi Province Patentee after: Tianyuan Jiangxi Pharmaceutical Co., Ltd. Address before: 226100 Yuet Lai town government hall, Haimen, Nantong, Jiangsu Patentee before: Nantong Yue Yue Industrial Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200806 Address after: 363000, Zhangzhou, Fujian province Zhangpu Sui An Industrial Zone Patentee after: TONGYITANG PHARMACEUTICAL Co.,Ltd. Address before: 331200 Chengbei Industrial Zone, Zhangshu City, Jiangxi, Yichun Patentee before: JIANGXI TIANYUAN MEDICINE Co.,Ltd. |